Human Genome Sciences, Inc.

Human Genome Sciences, Inc.

Human Genome Sciences, Inc.

Overview
Date Founded

1992

Headquarters

14200 Shady Grove Road,Rockville, MD 20850-7464

Type of Company

Private

Employees (Worldwide)

10K - 1M

Industries

Pharmaceuticals
Medical Support Services
Medical Products & Equipment
Hospitals & Patient Services
Biotechnology

Company Description

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Contact Data
Trying to get in touch with decision makers at Human Genome Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chairman

Chief Financial Officer & Senior Vice President

General Manager

Head of Immunology Research, Pharmacokinetics & Toxicology Groups

Director & Vice President

Board of Directors

Co-Founder at Rho Capital Partners, Inc.

Director & Vice President at Human Genome Sciences, Inc.

Head of BioPharmaceuticals Research & Development at RadEX Co., Ltd.

Paths to Human Genome Sciences, Inc.
Potential Connections via
Relationship Science
You
Human Genome Sciences, Inc.
Recent Transactions
Details Hidden

GlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Details Hidden

Human Genome Sciences, Inc. issued USD Common Stock

Details Hidden

Human Genome Sciences, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Underwriter

Advised onHuman Genome Sciences, Inc. issued USD Common Stock

Underwriter

Advised onHuman Genome Sciences, Inc. issued USD Common Stock

Head, Biotechnology Investment Banking

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Founding Partner

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Partner

Advised onGlaxoSmithKline Plc purchases Human Genome Sciences, Inc.

Advisors & Consultants
Legal Advisor

Partner at Simpson Thacher & Bartlett LLP

Legal Advisor

Partner at DLA Piper

Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Non-Profit Donations & Grants
Political Donations
$1,000
1997
Investments
Details Hidden

TriGenesys, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Human Genome Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Human Genome Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Human Genome Sciences, Inc..